Literature DB >> 22736231

Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia.

Hirozumi Sano1, Ryoji Kobayashi, Daisuke Suzuki, Kazue Yasuda, Masanori Nakanishi, Tetsuro Nagashima, Masafumi Yamada, Kunihiko Kobayashi.   

Abstract

A male infant exhibited thrombocytopenia at birth, and later developed leukocytosis, monocytosis, and bloody stool. The bone marrow was hypercellular with dysplasia. Spontaneous granulocyte/macrophage-colony formation and hypersensitivity to granulocyte/macrophage-colony stimulating factor were confirmed by in vitro culture. These findings fulfilled most of the diagnostic criteria for juvenile myelomonocytic leukemia (JMML), with the exception of splenomegaly. However, no mutations in the PTPN11, RAS, and CBL genes, or clinical features of neurofibromatosis type 1, which are associated with JMML, were detected. The patient subsequently developed refractory eczema with undetectable serum IgM, which led to the consideration of Wiskott-Aldrich syndrome (WAS). Lack of WASP expression and a 4-nucleotide deletion mutation in WASP were identified. Approximately 20 % of patients with JMML show none of the abovementioned molecular abnormalities. Careful differential diagnosis, including the consideration of WAS, is, therefore, recommended in patients with clinical features and laboratory findings consistent with JMML.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736231     DOI: 10.1007/s12185-012-1130-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

1.  CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.

Authors:  N Shiba; M Kato; M-j Park; M Sanada; E Ito; K Fukushima; M Sako; H Arakawa; S Ogawa; Y Hayashi
Journal:  Leukemia       Date:  2010-04-01       Impact factor: 11.528

Review 2.  Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors:  C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

3.  Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.

Authors:  Ryoji Kobayashi; Tadashi Ariga; Shigeaki Nonoyama; Hirokazu Kanegane; Shigeru Tsuchiya; Tomohiro Morio; Hiromasa Yabe; Yoshihisa Nagatoshi; Keisei Kawa; Ken Tabuchi; Masahiro Tsuchida; Toshio Miyawaki; Shunichi Kato
Journal:  Br J Haematol       Date:  2006-11       Impact factor: 6.998

4.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Marco Tartaglia; Charlotte M Niemeyer; Alessandra Fragale; Xiaoling Song; Jochen Buechner; Andreas Jung; Karel Hählen; Henrik Hasle; Jonathan D Licht; Bruce D Gelb
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

5.  RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML).

Authors:  C Flotho; S Valcamonica; S Mach-Pascual; G Schmahl; L Corral; J Ritterbach; H Hasle; M Aricò; A Biondi; C M Niemeyer
Journal:  Leukemia       Date:  1999-01       Impact factor: 11.528

6.  Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.

Authors:  Mignon L Loh; Debbie S Sakai; Christian Flotho; Michelle Kang; Manfred Fliegauf; Sophie Archambeault; Charles G Mullighan; Leslie Chen; Eva Bergstraesser; Carlos E Bueso-Ramos; Peter D Emanuel; Henrik Hasle; Jean-Pierre Issa; Marry M van den Heuvel-Eibrink; Franco Locatelli; Jan Stary; Monica Trebo; Marcin Wlodarski; Marco Zecca; Kevin M Shannon; Charlotte M Niemeyer
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

7.  Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features.

Authors:  Nobuhiro Watanabe; Ayami Yoshimi; Yoshiro Kamachi; Takashi Kawabe; Hideki Muramatsu; Kimikazu Matsumoto; Atsushi Manabe; Seiji Kojima; Koji Kato
Journal:  J Pediatr Hematol Oncol       Date:  2007-12       Impact factor: 1.289

Review 8.  Mechanisms of WASp-mediated hematologic and immunologic disease.

Authors:  Siobhan Burns; Giles O Cory; William Vainchenker; Adrian J Thrasher
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

9.  Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.

Authors:  I Kataoka; M Kami; S Takahashi; Y Kodera; S Miyawaki; N Hirabayashi; S Okamoto; N Matsumoto; Y Miyazaki; Y Morishita; O Asai; A Maruta; T Yoshida; M Imamura; N Hamajima; K Matsuo; M Harada; S Mineishi
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

Review 10.  Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.

Authors:  Charlotte Marie Niemeyer; Christian Peter Kratz
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

View more
  3 in total

1.  Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.

Authors:  Hamilton C Tsang; James B Bussel; Susan Mathew; Yen-Chun Liu; Allison A Imahiyerobo; Attilio Orazi; Julia T Geyer
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

2.  The genomic landscape of juvenile myelomonocytic leukemia.

Authors:  Elliot Stieglitz; Amaro N Taylor-Weiner; Tiffany Y Chang; Laura C Gelston; Yong-Dong Wang; Tali Mazor; Emilio Esquivel; Ariel Yu; Sara Seepo; Scott Olsen; Mara Rosenberg; Sophie L Archambeault; Ghada Abusin; Kyle Beckman; Patrick A Brown; Michael Briones; Benjamin Carcamo; Todd Cooper; Gary V Dahl; Peter D Emanuel; Mark N Fluchel; Rakesh K Goyal; Robert J Hayashi; Johann Hitzler; Christopher Hugge; Y Lucy Liu; Yoav H Messinger; Donald H Mahoney; Philip Monteleone; Eneida R Nemecek; Philip A Roehrs; Reuven J Schore; Kimo C Stine; Clifford M Takemoto; Jeffrey A Toretsky; Joseph F Costello; Adam B Olshen; Chip Stewart; Yongjin Li; Jing Ma; Robert B Gerbing; Todd A Alonzo; Gad Getz; Tanja Gruber; Todd Golub; Kimberly Stegmaier; Mignon L Loh
Journal:  Nat Genet       Date:  2015-10-12       Impact factor: 38.330

3.  Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience

Authors:  Şule Haskoloğlu; Ayşenur Öztürk; Gökcan Öztürk; Sevgi Kostel Bal; Candan İslamoğlu; Kübra Baskın; Serdar Ceylaner; Lale Tufan Satıroğlu; Figen Doğu; Aydan İkincioğulları
Journal:  Turk J Haematol       Date:  2020-08-19       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.